top of page

Adopting mainstream strategies in drug development

Discovering a new chemical entity to treat a disease is a time-consuming, risky and costly process. It can cost over one billion USD and 10-15 years to bring a new chemical entity to market with only a 1 in 10,000 success rate.

 

Drug repurposing or repositioning is a fairly recent but widely accepted approach that involves developing existing drugs for new diseases.  This can significantly reduce the risk, cost and time for development.

 

Repurposed drugs now command 25% of worldwide drug revenues estimated at one trillion USD annually

REPURPOSING

●  Speeds up transition from bench
    to bedside

●  Substantially reduces 
    development risks and costs

●  Ensures accessible, sustainable
    and affordable cancer treatment

REPURPOSINGNG

REFORMULATING

●  Enhances bioavailability

●  Optimises dose

●  Improves patient compliance 
    through reduced pill burden

GOLD STANDARD
MODELLING AND
SIMULATION

●  Assists with in vitro research and
    in vivo research

●  Predicts optimal human dosing
    regimen

bottom of page